Interventional Cardiology Global Market - Forecast to 2023
Interventional cardiology specifically deals with the catheter based treatment of cardiovascular and structural heart diseases. Products of interventional cardiology market are Catheters, Interventional Diagnostic Catheters, stents, valves, transcatheter heart pump and others. Catheters are segmented into Guide Catheter, Balloon Catheter, Atherectomy Catheters, Thrombectomy Catheters, and Ablation Catheters. Interventional Diagnostic Catheters are segmented into Intravascular ultrasound (IVUS), Fractional flow reserve (FFR), Optical coherence tomography (OCT), Angiograph, Pulmonary artery catheter, Electrophysiology catheter. Stents are further categorised into bare metal stents, drug eluting stents, Bioresorbable stents and Stent grafts. Valves are further divided into Transcatheter Aortic Valve, Annuloplasty Ring, Mitral Clip, and Valvuloplasty. Others are segmented into closure devices (Occluders), Inferior vena cava filters, Guide wires, Transcatheter pacemaker, and accessories.
Applications of Interventional cardiology market are segmented into Diagnostic catheterization, Coronary Interventions, Peripheral interventions and Structural Heart. Coronary intervention application is sub-segmented into Aortic aneurysm (EAVR, TEVAR), Coronary Thrombectomy, PCTA, Coronary Cardiac Ablation and others. Peripheral interventions are sub-segmented into Peripheral Aneurysm, Peripheral Thrombectomy, Peripheral Angioplasty, Peripheral Ablation, Pulmonary embolism, and others. Structural heart is further sub-segmented into Valve replacement, Valve repair, Heart Assist Device, Congenital heart defect and others.
The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach $46,124.1 million by 2023. Among the Interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, Transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, Coronary Interventions is the largest segment and Structural Heart is the fastest growing segment with the strong CAGR.
Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
Increasing incidences of cardiovascular diseases due to change in lifestyle, Demand for minimally invasive treatment due to less complication, Rise in the number of Cardiovascular disorders and ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the Interventional cardiology global market. Many entry level barriers, stringent regulation and lack of skilled and trained professionals are some of the factors hampering the growth of Interventional cardiology market.
The interventional cardiology global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the interventional cardiology market are Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.).
Applications of Interventional cardiology market are segmented into Diagnostic catheterization, Coronary Interventions, Peripheral interventions and Structural Heart. Coronary intervention application is sub-segmented into Aortic aneurysm (EAVR, TEVAR), Coronary Thrombectomy, PCTA, Coronary Cardiac Ablation and others. Peripheral interventions are sub-segmented into Peripheral Aneurysm, Peripheral Thrombectomy, Peripheral Angioplasty, Peripheral Ablation, Pulmonary embolism, and others. Structural heart is further sub-segmented into Valve replacement, Valve repair, Heart Assist Device, Congenital heart defect and others.
The interventional cardiology global market is expected to grow at a CAGR of high single digit CAGR to reach $46,124.1 million by 2023. Among the Interventional cardiology products, the stents market dominated the products market by occupying a largest share. At the same time, Transcatheter heart pump market is the fastest growing segment projected to grow at a high double digit CAGR. In applications, Coronary Interventions is the largest segment and Structural Heart is the fastest growing segment with the strong CAGR.
Geographical wise, North America is the largest market followed by Europe and Asia-Pacific. The APAC region is projected to be the fastest growing region suggesting an opportunities for growth and likely to get attention of new investors in the interventional cardiology market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases, ageing population and government initiatives in establishing innovative technologies.
Increasing incidences of cardiovascular diseases due to change in lifestyle, Demand for minimally invasive treatment due to less complication, Rise in the number of Cardiovascular disorders and ageing population, awareness of minimally invasive procedures and newly invented devices, raise in number of clinical studies performed are some of the drivers in the Interventional cardiology global market. Many entry level barriers, stringent regulation and lack of skilled and trained professionals are some of the factors hampering the growth of Interventional cardiology market.
The interventional cardiology global market is a consolidated, highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the interventional cardiology market are Abbott Laboratories (U.S.), Boston Scientific (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Edwards Lifesciences (U.S.), Medtronic PLC (Ireland), Terumo Corporation (Japan), Johnson & Johnson (U.S.).
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in prevalence of cardiovascular disorders due to rise
in aging population
3.3.1.2 Increasing number of interventional procedures
3.3.1.3 Rise in the number of clinical studies performed
3.3.1.4 Increasing prevalence of lifestyle diseases
3.3.1.5 Technology advancements and growing healthcare budgetary allocation
3.3.1.6 Growth in emerging countries
3.3.1.7 Increase in patient awareness for minimal invasive surgeries
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Stringent regulatory requirements with high cost of development
3.3.2.2 Lack of skilled and trained professionals
3.3.2.3 Availability of alternatives products and procedures
3.3.2.4 Reimbursement issues in emerging countries
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 CHINA
3.4.6 JAPAN
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT Table
3.5.1.1 Diagnostic cardiac catheterization
3.5.1.2 Coronary angioplasty (PTCA), without stent
3.5.1.3 Coronary atherectomy (PTCA), without stent
3.5.1.4 Non-drug-eluting stent with angioplasty (PTCA)
3.5.1.5 Drug-eluting stent with angioplasty (PTCA)
3.5.1.6 Non drug-eluting stent with atherectomy
3.5.1.7 Drug-eluting stent with atherectomy
3.5.1.8 Non-drug-eluting stent coronary revascularization
3.5.1.9 Acute myocardial infarction
3.5.1.10 Chronic total occlusion
3.5.1.11 Drug-eluting stent coronary revascularization
3.5.1.12 Acute myocardial infarction
3.5.1.13 Chronic total occlusion
3.5.1.14 Intravascular ultrasound
3.5.1.15 Fractional flow reserve
3.5.1.16 Intravascular ultrasound (peripheral interventions)
3.5.1.17 Percutaneous balloon valvuloplasty; aortic valve
3.5.1.18 Endovascular or transthoracic valves
3.5.1.19 Watchman tm left atrial appendage closure (LAAC) procedure
3.5.1.20 Thrombectomy
3.5.1.21 Aneurysm
3.6 CLINICL TRIAL DATA
3.7 PATENT TRENDS
3.8 TECHNOLOGICAL ADVANCEMENTS
3.8.1 INTRODUCTION
3.8.2 CARDIAC OR VENTRICULAR REMODELLING AND HEART PUMP
3.8.3 TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR)
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 BARGAINING POWER OF SUPPLIERS
3.9.4 BARGAINING POWER OF BUYERS
3.9.5 COMPETITIVE RIVALRY
3.10 PEDIATRIC INTERVENTIONAL CARDIOLOGY
3.11 SUPPLY CHAIN ANALYSIS
3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 CATHETERS
4.2.1 GUIDE CATHETER
4.2.2 BALLOON CATHETERS
4.2.3 ATHERECTOMY CATHETERS
4.2.3.1 Directional atherectomy catheter
4.2.3.2 Rotational atherectomy catheter
4.2.3.3 Orbital atherectomy catheter
4.2.3.4 Laser atherectomy catheter
4.2.4 THROMBECTOMY CATHETERS
4.2.5 ABLATION CATHETERS
4.2.5.1 Radiofrequency ablation
4.2.5.2 Others
4.3 INTERVENTIOAL DIAGNOSTIC CATHETERS
4.3.1 INTRAVASCULAR ULTRASOUND (IVUS) CATHETER
4.3.2 FRACTIONAL FLOW RESERVE (FFR) CATHETER
4.3.3 OPTICAL COHERENCE TOMOGRAPHY (OCT) CATHETER
4.3.4 ANGIOGRAPHIC CATHETER
4.3.5 PULMONARY ARTERY CATHETER (PAC)
4.3.6 ELECTROPHYSIOLOGY CATHETER
4.4 STENTS
4.4.1 BARE METAL STENTS
4.4.2 DRUG ELUTING STENTS
4.4.3 BIORESORBABLE STENTS
4.4.4 STENT GRAFTS
4.5 VALVES
4.5.1 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
4.5.2 ANNULOPLASTY RING
4.5.3 MITRAL CLIP
4.5.4 VALVULOPLASTY
4.6 TRANSCATHETER HEART PUMP
4.7 OTHERS
4.7.1 OCCLUDERS
4.7.2 INFERIOR VENA CAVA FILTERS
4.7.3 OTHERS
5 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 DIAGNOSTIC CATHETERIZATION
5.3 CORONARY INTERVENTIONS
5.3.1 AORTIC ANEURYSM
5.3.2 CORONARY THROMBECTOMY
5.3.3 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
5.3.4 CORONARY ABLATION
5.3.5 OTHER CORONARY INTERVENTIONS
5.4 PERIPHERAL INTERVENTIONS
5.4.1 PERIPHERAL ANEURYSM
5.4.2 PERIPHERAL THROMBECTOMY
5.4.3 PERIPHERAL ANGIOPLASTY
5.4.4 PERIPHERAL ABLATION
5.4.5 PULMONARY EMBOLISM
5.4.6 OTHER PERIPHERAL INTERVENTIONS
5.5 STRUCTURAL HEART
5.5.1 VALVE REPLACEMENT
5.5.2 VALVE REPAIR (MITRAL CLIP)
5.5.3 HEART ASSIST DEVICE
5.5.4 CONGENITAL HEART DEFECT
5.5.5 OTHERS
6 REGIONAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.2.2 OTHERS
6.3 EUROPE
6.3.1 GERMANY
6.3.2 FRANCE
6.3.3 U.K.
6.3.4 OTHERS
6.4 APAC
6.4.1 JAPAN
6.4.2 CHINA
6.4.3 INDIA
6.4.4 OTHERS
6.5 ROW
6.5.1 BRAZIL
6.5.2 MIDDLE EAST
6.5.3 OTHERS
7 COMPANY DEVELOPMENTS
7.1 INTRODUCTION
7.2 APPROVALS
7.3 ACQUISITIONS AND MERGERS
7.4 NEW PRODUCT LAUNCH
7.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS AND JOINT VENTURES
7.6 OTHER DEVELOPMENTS
8 MAJOR COMPANIES
8.1 ABBOTT LABORATORIES
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 ABIOMED
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 B.BRAUN MELSUNGEN AG
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 BOSTON SCIENTIFIC CORPOARTION
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 C.R.BARD INC.
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 COOK MEDICAL, INC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 EDWARDS LIFESCIENCES CORP.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 JOHNSON & JOHNSON (BIOSENSE WEBSTER)
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 MEDTRONIC PLC
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 TERUMO CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
8.11 W.L. GORE & ASSOCIATES, INC.
8.11.1 OVERVIEW
8.11.2 FINANCIALS
8.11.3 PRODUCT PORTFOLIO
8.11.4 KEY DEVELOPMENTS
8.11.5 BUSINESS STRATEGY
8.11.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increase in prevalence of cardiovascular disorders due to rise
in aging population
3.3.1.2 Increasing number of interventional procedures
3.3.1.3 Rise in the number of clinical studies performed
3.3.1.4 Increasing prevalence of lifestyle diseases
3.3.1.5 Technology advancements and growing healthcare budgetary allocation
3.3.1.6 Growth in emerging countries
3.3.1.7 Increase in patient awareness for minimal invasive surgeries
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Stringent regulatory requirements with high cost of development
3.3.2.2 Lack of skilled and trained professionals
3.3.2.3 Availability of alternatives products and procedures
3.3.2.4 Reimbursement issues in emerging countries
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.2 U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 CHINA
3.4.6 JAPAN
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT Table
3.5.1.1 Diagnostic cardiac catheterization
3.5.1.2 Coronary angioplasty (PTCA), without stent
3.5.1.3 Coronary atherectomy (PTCA), without stent
3.5.1.4 Non-drug-eluting stent with angioplasty (PTCA)
3.5.1.5 Drug-eluting stent with angioplasty (PTCA)
3.5.1.6 Non drug-eluting stent with atherectomy
3.5.1.7 Drug-eluting stent with atherectomy
3.5.1.8 Non-drug-eluting stent coronary revascularization
3.5.1.9 Acute myocardial infarction
3.5.1.10 Chronic total occlusion
3.5.1.11 Drug-eluting stent coronary revascularization
3.5.1.12 Acute myocardial infarction
3.5.1.13 Chronic total occlusion
3.5.1.14 Intravascular ultrasound
3.5.1.15 Fractional flow reserve
3.5.1.16 Intravascular ultrasound (peripheral interventions)
3.5.1.17 Percutaneous balloon valvuloplasty; aortic valve
3.5.1.18 Endovascular or transthoracic valves
3.5.1.19 Watchman tm left atrial appendage closure (LAAC) procedure
3.5.1.20 Thrombectomy
3.5.1.21 Aneurysm
3.6 CLINICL TRIAL DATA
3.7 PATENT TRENDS
3.8 TECHNOLOGICAL ADVANCEMENTS
3.8.1 INTRODUCTION
3.8.2 CARDIAC OR VENTRICULAR REMODELLING AND HEART PUMP
3.8.3 TRANSCATHETER MITRAL VALVE REPLACEMENT (TMVR)
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 BARGAINING POWER OF SUPPLIERS
3.9.4 BARGAINING POWER OF BUYERS
3.9.5 COMPETITIVE RIVALRY
3.10 PEDIATRIC INTERVENTIONAL CARDIOLOGY
3.11 SUPPLY CHAIN ANALYSIS
3.12 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
4 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY PRODUCT
4.1 INTRODUCTION
4.2 CATHETERS
4.2.1 GUIDE CATHETER
4.2.2 BALLOON CATHETERS
4.2.3 ATHERECTOMY CATHETERS
4.2.3.1 Directional atherectomy catheter
4.2.3.2 Rotational atherectomy catheter
4.2.3.3 Orbital atherectomy catheter
4.2.3.4 Laser atherectomy catheter
4.2.4 THROMBECTOMY CATHETERS
4.2.5 ABLATION CATHETERS
4.2.5.1 Radiofrequency ablation
4.2.5.2 Others
4.3 INTERVENTIOAL DIAGNOSTIC CATHETERS
4.3.1 INTRAVASCULAR ULTRASOUND (IVUS) CATHETER
4.3.2 FRACTIONAL FLOW RESERVE (FFR) CATHETER
4.3.3 OPTICAL COHERENCE TOMOGRAPHY (OCT) CATHETER
4.3.4 ANGIOGRAPHIC CATHETER
4.3.5 PULMONARY ARTERY CATHETER (PAC)
4.3.6 ELECTROPHYSIOLOGY CATHETER
4.4 STENTS
4.4.1 BARE METAL STENTS
4.4.2 DRUG ELUTING STENTS
4.4.3 BIORESORBABLE STENTS
4.4.4 STENT GRAFTS
4.5 VALVES
4.5.1 TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
4.5.2 ANNULOPLASTY RING
4.5.3 MITRAL CLIP
4.5.4 VALVULOPLASTY
4.6 TRANSCATHETER HEART PUMP
4.7 OTHERS
4.7.1 OCCLUDERS
4.7.2 INFERIOR VENA CAVA FILTERS
4.7.3 OTHERS
5 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 DIAGNOSTIC CATHETERIZATION
5.3 CORONARY INTERVENTIONS
5.3.1 AORTIC ANEURYSM
5.3.2 CORONARY THROMBECTOMY
5.3.3 PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA)
5.3.4 CORONARY ABLATION
5.3.5 OTHER CORONARY INTERVENTIONS
5.4 PERIPHERAL INTERVENTIONS
5.4.1 PERIPHERAL ANEURYSM
5.4.2 PERIPHERAL THROMBECTOMY
5.4.3 PERIPHERAL ANGIOPLASTY
5.4.4 PERIPHERAL ABLATION
5.4.5 PULMONARY EMBOLISM
5.4.6 OTHER PERIPHERAL INTERVENTIONS
5.5 STRUCTURAL HEART
5.5.1 VALVE REPLACEMENT
5.5.2 VALVE REPAIR (MITRAL CLIP)
5.5.3 HEART ASSIST DEVICE
5.5.4 CONGENITAL HEART DEFECT
5.5.5 OTHERS
6 REGIONAL ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.2.1 U.S.
6.2.2 OTHERS
6.3 EUROPE
6.3.1 GERMANY
6.3.2 FRANCE
6.3.3 U.K.
6.3.4 OTHERS
6.4 APAC
6.4.1 JAPAN
6.4.2 CHINA
6.4.3 INDIA
6.4.4 OTHERS
6.5 ROW
6.5.1 BRAZIL
6.5.2 MIDDLE EAST
6.5.3 OTHERS
7 COMPANY DEVELOPMENTS
7.1 INTRODUCTION
7.2 APPROVALS
7.3 ACQUISITIONS AND MERGERS
7.4 NEW PRODUCT LAUNCH
7.5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS AND JOINT VENTURES
7.6 OTHER DEVELOPMENTS
8 MAJOR COMPANIES
8.1 ABBOTT LABORATORIES
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCT PORTFOLIO
8.1.4 KEY DEVELOPMENTS
8.1.5 BUSINESS STRATEGY
8.1.6 SWOT ANALYSIS
8.2 ABIOMED
8.2.1 OVERVIEW
8.2.2 FINANCIALS
8.2.3 PRODUCT PORTFOLIO
8.2.4 KEY DEVELOPMENTS
8.2.5 BUSINESS STRATEGY
8.2.6 SWOT ANALYSIS
8.3 B.BRAUN MELSUNGEN AG
8.3.1 OVERVIEW
8.3.2 FINANCIALS
8.3.3 PRODUCT PORTFOLIO
8.3.4 KEY DEVELOPMENTS
8.3.5 BUSINESS STRATEGY
8.3.6 SWOT ANALYSIS
8.4 BOSTON SCIENTIFIC CORPOARTION
8.4.1 OVERVIEW
8.4.2 FINANCIALS
8.4.3 PRODUCT PORTFOLIO
8.4.4 KEY DEVELOPMENTS
8.4.5 BUSINESS STRATEGY
8.4.6 SWOT ANALYSIS
8.5 C.R.BARD INC.
8.5.1 OVERVIEW
8.5.2 FINANCIALS
8.5.3 PRODUCT PORTFOLIO
8.5.4 KEY DEVELOPMENTS
8.5.5 BUSINESS STRATEGY
8.5.6 SWOT ANALYSIS
8.6 COOK MEDICAL, INC.
8.6.1 OVERVIEW
8.6.2 FINANCIALS
8.6.3 PRODUCT PORTFOLIO
8.6.4 KEY DEVELOPMENTS
8.6.5 BUSINESS STRATEGY
8.6.6 SWOT ANALYSIS
8.7 EDWARDS LIFESCIENCES CORP.
8.7.1 OVERVIEW
8.7.2 FINANCIALS
8.7.3 PRODUCT PORTFOLIO
8.7.4 KEY DEVELOPMENTS
8.7.5 BUSINESS STRATEGY
8.7.6 SWOT ANALYSIS
8.8 JOHNSON & JOHNSON (BIOSENSE WEBSTER)
8.8.1 OVERVIEW
8.8.2 FINANCIALS
8.8.3 PRODUCT PORTFOLIO
8.8.4 KEY DEVELOPMENTS
8.8.5 BUSINESS STRATEGY
8.8.6 SWOT ANALYSIS
8.9 MEDTRONIC PLC
8.9.1 OVERVIEW
8.9.2 FINANCIALS
8.9.3 PRODUCT PORTFOLIO
8.9.4 KEY DEVELOPMENTS
8.9.5 BUSINESS STRATEGY
8.9.6 SWOT ANALYSIS
8.10 TERUMO CORPORATION
8.10.1 OVERVIEW
8.10.2 FINANCIALS
8.10.3 PRODUCT PORTFOLIO
8.10.4 KEY DEVELOPMENTS
8.10.5 BUSINESS STRATEGY
8.10.6 SWOT ANALYSIS
8.11 W.L. GORE & ASSOCIATES, INC.
8.11.1 OVERVIEW
8.11.2 FINANCIALS
8.11.3 PRODUCT PORTFOLIO
8.11.4 KEY DEVELOPMENTS
8.11.5 BUSINESS STRATEGY
8.11.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION, (2015 - 2023) ($MN)
Table 2 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 3 CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 4 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 5 GUIDE CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 6 BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 7 ATHERECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 8 THROMBECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 9 ABLATION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 10 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 11 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 12 IVUS CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 13 FFR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 14 OCT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 15 ANGIOGRAPHIC CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 16 PULMONARY ARTERY CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 17 ELECTROPHYSIOLOGY CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 18 STENTS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 19 STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 20 BARE METAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 21 DRUG ELUTING STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 22 BIORESORBABLE STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 23 STENT GRAFTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 24 VALVES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 25 VALVES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 26 TRANSCATHETER AORTIC VALVE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 27 ANNULOPLASTY RING GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 28 MITRAL CLIP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 29 VALVULOPLASTY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 30 TRANSCATHETER HEART PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 31 OTHERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 32 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 33 OCCLUDERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 34 INFERIOR VENA CAVA FILTERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 35 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 36 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 37 DIAGNOSTIC CATHETERIZATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 38 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 39 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 40 AORTIC ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 41 CORONARY THROMBECTOMY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 42 PTCA GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 43 CORONARY ABLATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 44 OTHER CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 45 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 46 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 47 PERIPHERAL ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 48 PERIPHERAL THROMBECTOMY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 49 PERIPHERAL ANGIOPLASTY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 50 PERIPHERAL ABLATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 51 PULMONARY EMBOLISM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 52 OTHER PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 53 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 54 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 55 VALVE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 56 VALVE REPAIR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 57 HEART ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 58 CONGENITAL HEART DEFECT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 59 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 60 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 61 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 62 NORTH AMERICAN CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 63 NORTH AMERICAN INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 64 NORTH AMERICAN STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 65 NORTH AMERICAN VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 66 NORTH AMERICAN OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 67 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 68 NORTH AMERICAN CORONARY INTERVENTIONS MARKET REVENUE,BY TYPE, (2015-2023) ($MN)
Table 69 NORTH AMERICAN PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 70 NORTH AMERICAN STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 71 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 72 U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 73 U.S INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 74 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Table 75 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 76 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 77 EUROPE CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 78 EUROPE INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 79 EUROPE STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 80 EUROPE VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 81 EUROPE OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 82 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 83 EUROPE CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 84 EUROPE PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 85 EUROPE STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 86 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 87 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 88 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 89 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 90 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 91 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 92 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 93 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 94 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 95 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 96 APAC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 97 APAC INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 98 APAC STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 99 APAC VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 100 APAC OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 101 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 102 APAC CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 103 APAC PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 104 APAC STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 105 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 106 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 107 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 108 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 109 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 110 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 111 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 112 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 113 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 114 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 115 ROW CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 116 ROW INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 117 ROW STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 118 ROW VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 119 ROW OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 120 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 121 ROW CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 122 ROW PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 123 ROW STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 124 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 125 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 126 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 127 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 128 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 129 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 130 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 131 APPROVALS, (2014-2017)
Table 132 ACQUISITIONS AND MERGERS, (2014-2017)
Table 133 NEW PRODUCT LAUNCH, (2014-2017)
Table 134 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, (2014-2017)
Table 135 OTHER DEVELOPMENTS (2014-2017)
Table 136 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 137 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2014-16) ($MN)
Table 138 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
Table 139 ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 140 ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 141 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 142 B.BRAUN MELSENGEN AG: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 143 B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 144 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 145 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
Table 146 BOSTON SCIENTIFIC CORPORATION: CARDIOVASCULAR REVENUE, BY SUB-SEGMNETS, (2014-2016) ($MN)
Table 147 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
Table 148 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 149 C.R.BARD INC: TOTAL REVENUE BY SEGMENTS (2014-16) ($MN)
Table 150 C.R. BARD: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 151 EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 152 EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 153 EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 154 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 155 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 156 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 157 MEDTRONIC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 158 MEDTRONIC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 159 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 160 MEDTRONIC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 161 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 162 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 163 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 1 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION, (2015 - 2023) ($MN)
Table 2 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 3 CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 4 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 5 GUIDE CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 6 BALLOON CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 7 ATHERECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 8 THROMBECTOMY CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 9 ABLATION CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 10 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 11 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 12 IVUS CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 13 FFR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 14 OCT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 15 ANGIOGRAPHIC CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 16 PULMONARY ARTERY CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 17 ELECTROPHYSIOLOGY CATHETER GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 18 STENTS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 19 STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 20 BARE METAL STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 21 DRUG ELUTING STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 22 BIORESORBABLE STENTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 23 STENT GRAFTS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 24 VALVES GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 25 VALVES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 26 TRANSCATHETER AORTIC VALVE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 27 ANNULOPLASTY RING GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 28 MITRAL CLIP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 29 VALVULOPLASTY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 30 TRANSCATHETER HEART PUMP GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 31 OTHERS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 32 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 33 OCCLUDERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 34 INFERIOR VENA CAVA FILTERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 35 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 36 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 37 DIAGNOSTIC CATHETERIZATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 38 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 39 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 40 AORTIC ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 41 CORONARY THROMBECTOMY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 42 PTCA GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 43 CORONARY ABLATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 44 OTHER CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 45 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 46 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 47 PERIPHERAL ANEURYSM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 48 PERIPHERAL THROMBECTOMY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 49 PERIPHERAL ANGIOPLASTY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 50 PERIPHERAL ABLATION GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 51 PULMONARY EMBOLISM GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 52 OTHER PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 53 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 54 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 55 VALVE REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 56 VALVE REPAIR GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 57 HEART ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 58 CONGENITAL HEART DEFECT GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 59 OTHERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 60 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 61 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 62 NORTH AMERICAN CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 63 NORTH AMERICAN INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 64 NORTH AMERICAN STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 65 NORTH AMERICAN VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 66 NORTH AMERICAN OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 67 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 68 NORTH AMERICAN CORONARY INTERVENTIONS MARKET REVENUE,BY TYPE, (2015-2023) ($MN)
Table 69 NORTH AMERICAN PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 70 NORTH AMERICAN STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 71 NORTH AMERICAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 72 U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 73 U.S INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 74 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Table 75 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 76 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 77 EUROPE CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 78 EUROPE INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 79 EUROPE STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 80 EUROPE VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 81 EUROPE OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 82 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 83 EUROPE CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 84 EUROPE PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 85 EUROPE STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 86 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 87 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 88 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 89 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 90 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 91 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 92 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 93 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 94 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 95 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 96 APAC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 97 APAC INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 98 APAC STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 99 APAC VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 100 APAC OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 101 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 102 APAC CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 103 APAC PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 104 APAC STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 105 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 106 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 107 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 108 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 109 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 110 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 111 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 112 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 113 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 114 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2015-2023) ($MN)
Table 115 ROW CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 116 ROW INTERVENTIONAL DIAGNOSTIC CATHETERS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 117 ROW STENTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 118 ROW VALVES MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 119 ROW OTHER PRODUCTS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 120 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 121 ROW CORONARY INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 122 ROW PERIPHERAL INTERVENTIONS MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 123 ROW STRUCTURAL HEART MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 124 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY, (2015-2023) ($MN)
Table 125 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 126 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 127 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 128 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 129 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS, (2015-2023) ($MN)
Table 130 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 131 APPROVALS, (2014-2017)
Table 132 ACQUISITIONS AND MERGERS, (2014-2017)
Table 133 NEW PRODUCT LAUNCH, (2014-2017)
Table 134 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, (2014-2017)
Table 135 OTHER DEVELOPMENTS (2014-2017)
Table 136 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 137 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS, (2014-16) ($MN)
Table 138 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
Table 139 ABIOMED: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 140 ABIOMED: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 141 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
Table 142 B.BRAUN MELSENGEN AG: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
Table 143 B.BRAUN MELSENGEN, AG: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
Table 144 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 145 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2014-2016) ($MN)
Table 146 BOSTON SCIENTIFIC CORPORATION: CARDIOVASCULAR REVENUE, BY SUB-SEGMNETS, (2014-2016) ($MN)
Table 147 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY, (2014-2016) ($MN)
Table 148 C.R.BARD INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 149 C.R.BARD INC: TOTAL REVENUE BY SEGMENTS (2014-16) ($MN)
Table 150 C.R. BARD: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 151 EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 152 EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 153 EDWARDS LIFESCIENCES CORP.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 154 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 155 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 156 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 157 MEDTRONIC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 158 MEDTRONIC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 159 MEDTRONIC: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 160 MEDTRONIC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 161 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 162 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 163 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
LIST OF FIGURES
Figure 1 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
Figure 2 RESEARCH METHODOLOGY: INTERVENTIONAL CARDIOLOGY GLOBAL MARKET
Figure 3 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: FORECASTING MODEL
Figure 5 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 INTERVENTIONAL CARDIOLOGY MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 9 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
Figure 12 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY PRODUCTS (2016) ($MN)
Figure 13 CATHETERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 14 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 15 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 16 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY REGION (2016 V/S 2023) (%)
Figure 17 STENTS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 18 STENTS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) ($MN)
Figure 19 BIORESORBABLE STENTS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 20 VALVES GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 21 VALVES GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 22 ANNULOPLASTY RING GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 23 TRANSCATHETER HEART PUMP GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 24 OTHERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 25 OTHERS MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 26 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY APPLICATION, (2016) ($MN)
Figure 27 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
Figure 28 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 29 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
Figure 30 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 31 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
Figure 32 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 33 HEART ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 34 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN), CAGR (%)
Figure 35 NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 36 NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 37 NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 38 U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 39 U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 40 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 41 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 42 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 43 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 44 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 45 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 46 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 47 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 48 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 49 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 50 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 51 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 52 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 53 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 54 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 55 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 56 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 57 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 58 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 59 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 60 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 61 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 62 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 63 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 64 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 65 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 66 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 67 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 68 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 69 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 70 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 71 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 72 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 73 KEY GROWTH STRATEGIES, (2014-2017)
Figure 74 SWOT: ABBOTT LABORATORIES
Figure 75 SWOT: ABIOMED
Figure 76 SWOT: B.BRAUN MELSUNGEN, AG
Figure 77 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 78 SWOT: C.R.BARD, INC.
Figure 79 SWOT: COOK MEDICAL, INC.
Figure 80 SWOT: EDWARDS LIFESCIENCES
Figure 81 SWOT: JOHNSON & JOHNSON
Figure 82 SWOT: MEDTRONIC
Figure 83 SWOT: TERUMO CORPORATION
Figure 84 SWOT: W.L. GORE & ASSOCIATES, INC.
Figure 1 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION (2015-2023) ($MN)
Figure 2 RESEARCH METHODOLOGY: INTERVENTIONAL CARDIOLOGY GLOBAL MARKET
Figure 3 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: FORECASTING MODEL
Figure 5 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 INTERVENTIONAL CARDIOLOGY MARKET: PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 9 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: PORTER’S ANALYSIS
Figure 10 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 11 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 (%)
Figure 12 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY PRODUCTS (2016) ($MN)
Figure 13 CATHETERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 14 CATHETERS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 15 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 16 INTERVENTIONAL DIAGNOSTIC CATHETERS GLOBAL MARKET REVENUE, BY REGION (2016 V/S 2023) (%)
Figure 17 STENTS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 18 STENTS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) ($MN)
Figure 19 BIORESORBABLE STENTS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 20 VALVES GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 21 VALVES GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 22 ANNULOPLASTY RING GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 23 TRANSCATHETER HEART PUMP GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 24 OTHERS GLOBAL MARKET REVENUE, BY TYPE (2016 V/S 2023) ($MN)
Figure 25 OTHERS MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 26 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY APPLICATION, (2016) ($MN)
Figure 27 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
Figure 28 CORONARY INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 29 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
Figure 30 PERIPHERAL INTERVENTIONS GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 31 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY TYPE, (2016 V/S 2023) ($MN)
Figure 32 STRUCTURAL HEART GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 33 HEART ASSIST DEVICE GLOBAL MARKET REVENUE, BY REGION, (2016 V/S 2023) (%)
Figure 34 INTERVENTIONAL CARDIOLOGY GLOBAL MARKET REVENUE, BY REGION (2015 - 2023) ($MN), CAGR (%)
Figure 35 NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 36 NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 37 NORTH AMERICA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 38 U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 39 U.S. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 40 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 41 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 42 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 43 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 44 EUROPE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 45 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 46 GERMANY INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 47 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 48 FRANCE INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 49 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 50 U.K. INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 51 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 52 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 53 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 54 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 55 APAC INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 56 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 57 JAPAN INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 58 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 59 CHINA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 60 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 61 INDIA INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 62 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 63 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 64 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCT, (2016 V/S 2023) ($MN)
Figure 65 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION (2016 V/S 2023) ($MN)
Figure 66 ROW INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY COUNTRY (2016 V/S 2023) (%)
Figure 67 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 68 BRAZIL INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 69 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 70 MIDDLE EAST INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 71 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY PRODUCTS (2016 V/S 2023) ($MN)
Figure 72 OTHERS INTERVENTIONAL CARDIOLOGY MARKET REVENUE, BY APPLICATION, (2016 V/S 2023) ($MN)
Figure 73 KEY GROWTH STRATEGIES, (2014-2017)
Figure 74 SWOT: ABBOTT LABORATORIES
Figure 75 SWOT: ABIOMED
Figure 76 SWOT: B.BRAUN MELSUNGEN, AG
Figure 77 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 78 SWOT: C.R.BARD, INC.
Figure 79 SWOT: COOK MEDICAL, INC.
Figure 80 SWOT: EDWARDS LIFESCIENCES
Figure 81 SWOT: JOHNSON & JOHNSON
Figure 82 SWOT: MEDTRONIC
Figure 83 SWOT: TERUMO CORPORATION
Figure 84 SWOT: W.L. GORE & ASSOCIATES, INC.
